Extracorporeal Membrane Oxygenation Machine Market Segmentation:
Type
The veno-arterial segment in the extracorporeal membrane oxygenation machine market is estimated to gain the largest revenue share of 60%. Veno-arterial (VA) extracorporeal membrane oxygenation machine is an integral part of heart transplantation protocols since it provides vital support to the patient during the critical period between organ harvesting and implantation. This use of VA ECMO extends the viability of the heart donor by ensuring optimal conditions for successful transplantation. It is used as a mechanical device that has been utilized for circulatory support during cardiac arrest. According to the World Heart Federation in 2021, 20.5 million deaths occurred from cardiovascular disease. These factors are propelling the segment’s growth in the coming decade.
End Users
The hospital segment is expected to garner a significant share in the year 2035. Government initiatives that are enhancing critical care infrastructure in hospitals are contributing to the growth of extracorporeal membrane oxygenation machine utilization. Additionally, the increased funding for the expansion and refurbishment of critical care units is enabling hospitals to invest in innovative life support technologies, including the ECMO machine. The government is allocating critical care infrastructure, signifying the importance of resources for advanced technologies in hospitals. In April 2024, the World Bank group aimed to expand health services to 1.5 billion people by 2030.
Our in-depth analysis of the global extracorporeal membrane oxygenation machine market includes the following segments:
|
Type |
|
|
End User |
|
